Author Blennow, Kaj

• 2003 | Review
  ​ ​Clinical mass spectrometry in neuroscience. Proteomics and peptidomics​
  Davidsson, P.; Brinkmalm, A.; Karlsson, G.; Persson, R.; Lindbjer, M.; Puchades, M.& Folkesson, S. et al.​ (2003)
  CELLULAR AND MOLECULAR BIOLOGY, 49​(5) pp. 681​-688​.​
  Cellular & Molecular Biology.
  ​Details  PMID  PMC  WoS 

• 2004 | Journal Article
  ​ ​Value of CSF beta-amyloid(1-42) and tau as predictors of Alzheimer's disease in patients with mild cognitive impairment​
  Hampel, H.; Teipel, S. J.; Fuchsberger, T.; Andreasen, N.; Wiltfang, J.; Otto, M. & Shen, Y. et al.​ (2004) 
  Molecular Psychiatry, 9(7) pp. 705​-710​.​ DOI: https://doi.org/10.1038/sj.mp.4001473 
  ​Details  DOI  PMID  PMC  WoS 

• 2005 | Review
  ​ ​Consensus paper of the WFSBP Task Force on biological markers of dementia: The role of CSF and blood analysis in the early and differential diagnosis of dementia​
  Wiltfang, J.; Lewczuk, P.; Riederer, P.; Grunblatt, E.; Hock, C.; Scheltens, P.& Hampel, H. et al.​ (2005)
  The World Journal of Biological Psychiatry, 6​(2) pp. 69​-84​.​
  Taylor & Francis Ltd. DOI: https://doi.org/10.1080/15622970510029786 
  ​Details  DOI  PMID  PMC  WoS 

• 2006 | Journal Article
  ​ ​Dissociation between CSF total tau and tau protein phosphorylated at threonine 231 in Creutzfeldt-Jakob disease​
  Buerger, K.; Otto, M. ; Teipel, S. J.; Zinkowski, R.; Blennow, K.; DeBernardis, J. & Kerkman, D. et al.​ (2006) 
  Neurobiology of Aging, 27(1) pp. 10​-15​.​ DOI: https://doi.org/10.1016/j.neurobiolaging.2004.12.003 
  ​Details  DOI  PMID  PMC  WoS 

• 2009 | Review
  ​ ​Consensus Paper of the WFSBP Task Force on Biological Markers of Dementia: The role of CSF and blood analysis in the early and differential diagnosis of dementia​
  Wiltfang, J.; Lewczuk, P.; Riederer, P.; Gruenblatt, E.; Hock, C.; Scheltens, P.& Hampel, H. et al.​ (2009)
  REVISTA DE PSIQUIATRIA CLINICA, 36​ pp. 1​-16​.​
  Univ Sao Paulo, Inst Psiquiatria.
  ​Details  WoS 

• 2012 | Journal Article
  ​ ​Improved discrimination of AD patients using  β-amyloid(1-42) and tau levels in CSF​
  Hulstaert, F.; Blennow, K.; Ivanoiu, A.; Schoonderwaldt, H. C.; Riemenschneider, M.; Deyn, P. P. D. & Bancher, C. et al.​ (2012) 
  Neurology, 52(8).​ DOI: https://doi.org/10.1212/wnl.52.8.1555 
  ​Details  DOI 

• 2012 | Journal Article
  ​ ​Development and assessment of sensitive immuno-PCR assays for the quantification of cerebrospinal fluid three- and four-repeat tau isoforms in tauopathies​
  Luk, C.; Compta, Y.; Magdalinou, N.; Jose Marti, M.; Hondhamuni, G.; Zetterberg, H. & Blennow, K. et al.​ (2012) 
  Journal of Neurochemistry, 123(3) pp. 396​-405​.​ DOI: https://doi.org/10.1111/j.1471-4159.2012.07911.x 
  ​Details  DOI  PMID  PMC  WoS 

• 2012 | Journal Article
  ​ ​Pyroglutamate Amyloid beta (A beta) Aggravates Behavioral Deficits in Transgenic Amyloid Mouse Model for Alzheimer Disease​
  Wittnam, J. L.; Portelius, E.; Zetterberg, H.; Gustavsson, M. K.; Schilling, S.; Koch, B. & Demuth, H.-U. et al.​ (2012) 
  Journal of Biological Chemistry, 287(11) pp. 8154​-8162​.​ DOI: https://doi.org/10.1074/jbc.M111.308601 
  ​Details  DOI  PMID  PMC  WoS 

• 2015 | Journal Article | 
  ​ ​A practical guide to immunoassay method validation​
  Andreasson, U.; Perret-Liaudet, A.; van Waalwijk van Doorn, L. J. C.; Blennow, K.; Chiasserini, D.; Engelborghs, S. & Fladby, T. et al.​ (2015) 
  Frontiers in Neurology, 6 art. UNSP 179​.​ DOI: https://doi.org/10.3389/fneur.2015.00179 
  ​Details  DOI  PMID  PMC  WoS 

• 2015 | Journal Article
  ​ ​Validation of a quantitative cerebrospinal fluid alpha-synuclein assay in a European-wide interlaboratory study​
  Kruse, N.; Persson, S.; Alcolea, D.; Bahl, J. M. C.; Baldeiras, I.; Capello, E. & Chiasserini, D. et al.​ (2015) 
  Neurobiology of Aging, 36(9) pp. 2587​-2596​.​ DOI: https://doi.org/10.1016/j.neurobiolaging.2015.05.003 
  ​Details  DOI  PMID  PMC  WoS 

• 2015 | Journal Article | 
  ​ ​The central biobank and virtual biobank of BiOMarKaPD: a resource for studies on neurodegenerative diseases​
  Reijs, B. L. R.; Teunissen, C. E.; Goncharenko, N.; Betsou, F.; Blennow, K.; Baldeiras, I. & Brosseron, F. et al.​ (2015) 
  Frontiers in Neurology, 6 art. UNSP 216​.​ DOI: https://doi.org/10.3389/fneur.2015.00216 
  ​Details  DOI  PMID  PMC  WoS 

• 2016 | Journal Article
  ​ ​Comparison of Different Matrices as Potential Quality Control Samples for Neurochemical Dementia Diagnostics​
  Lelental, N.; Brandner, S.; Kofanova, O.; Blennow, K.; Zetterberg, H.; Andreasson, U. & Engelborghs, S. et al.​ (2016) 
  Journal of Alzheimer's Disease, 52(1) pp. 51​-64​.​ DOI: https://doi.org/10.3233/jad-150883 
  ​Details  DOI 

• 2018 | Journal Article
  ​ ​Biomarkers for Antidepressant Efficacy of Electroconvulsive Therapy: An Exploratory Cerebrospinal Fluid Study​
  Kranaster, L.; Hoyer, C.; Aksay, S.; Bumb, J.; Müller, N.; Zill, P. & Schwarz, M. et al.​ (2018) 
  Neuropsychobiology, 77(1) pp. 13​-22​.​ DOI: https://doi.org/10.1159/000491401 
  ​Details  DOI 

• 2018 | Journal Article
  ​ ​Cerebrospinal fluid and blood biomarkers for neurodegenerative dementias: An update of the Consensus of the Task Force on Biological Markers in Psychiatry of the World Federation of Societies of Biological Psychiatry​
  Lewczuk, P. ; Riederer, P.; O’Bryant, S. E.; Verbeek, M. M.; Dubois, B.; Visser, P. J. & Jellinger, K. A. et al.​ (2018) 
  The World Journal of Biological Psychiatry, 19(4) pp. 244​-328​.​ DOI: https://doi.org/10.1080/15622975.2017.1375556 
  ​Details  DOI 

• 2018 | Journal Article
  ​ ​Prevalence of the apolipoprotein E ε4 allele in amyloid β positive subjects across the spectrum of Alzheimer's disease​
  Mattsson, N.; Groot, C.; Jansen, W. J.; Landau, S. M.; Villemagne, V. L.; Engelborghs, S. & Mintun, M. M. et al.​ (2018) 
  Alzheimer's & Dementia, 14(7) pp. 913​-924​.​ DOI: https://doi.org/10.1016/j.jalz.2018.02.009 
  ​Details  DOI 

• 2018 | Journal Article | 
  ​ ​The presubiculum is preserved from neurodegenerative changes in Alzheimer’s disease​
  Murray, C. E; Gami-Patel, P.; Gkanatsiou, E.; Brinkmalm, G.; Portelius, E.; Wirths, O.   & Heywood, W. et al.​ (2018) 
  Acta Neuropathologica Communications, 6(1) art. 62​.​ DOI: https://doi.org/10.1186/s40478-018-0563-8 
  ​Details  DOI 

• 2018 | Journal Article | 
  ​ ​Interlaboratory proficiency processing scheme in CSF aliquoting: implementation and assessment based on biomarkers of Alzheimer’s disease​
  Lewczuk, P.; Gaignaux, A.; Kofanova, O.; Ermann, N.; Betsou, F.; Brandner, S. & Mroczko, B. et al.​ (2018) 
  Alzheimer's Research & Therapy, 10(1) art. 87​.​ DOI: https://doi.org/10.1186/s13195-018-0418-3 
  ​Details  DOI 

• 2018 | Journal Article | 
  ​ ​White paper by the Society for CSF Analysis and Clinical Neurochemistry: Overcoming barriers in biomarker development and clinical translation​
  Teunissen, C. E.; Otto, M. ; Engelborghs, S.; Herukka, S.-K.; Lehmann, S.; Lewczuk, P.   & Lleó, A. et al.​ (2018) 
  Alzheimer's Research & Therapy, 10(1).​ DOI: https://doi.org/10.1186/s13195-018-0359-x 
  ​Details  DOI 

• 2018 | Journal Article | 
  ​ ​Interlaboratory validation of cerebrospinal fluid α-synuclein quantification in the diagnosis of sporadic Creutzfeldt-Jakob disease​
  Kruse, N.; Heslegrave, A.; Gupta, V.; Foiani, M.; Villar-Piqué, A.; Schmitz, M. & Lehmann, S. et al.​ (2018) 
  Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring, 10 pp. 461​-470​.​ DOI: https://doi.org/10.1016/j.dadm.2018.06.005 
  ​Details  DOI  PMID  PMC 

• 2019 | Journal Article
  ​ ​The novel seizure quality index for the antidepressant outcome prediction in electroconvulsive therapy: association with biomarkers in the cerebrospinal fluid​
  Kranaster, L.; Hoyer, C.; Mindt, S.; Neumaier, M.; Müller, N.; Zill, P. & Schwarz, M. J. et al.​ (2019) 
  European Archives of Psychiatry and Clinical Neuroscience, 270(7) pp. 911​-919​.​ DOI: https://doi.org/10.1007/s00406-019-01086-x 
  ​Details  DOI 

Researcher

Sort

Items per Page